Osteolabs

Kiel, Germany Founded: 2019 • Age: 7 yrs
Diagnostic tests for osteoporosis are provided via urine-based biomarkers.
Annual revenue - Latest available
Total funding $1.1M 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors 9 Brand Intelligence

About Osteolabs

Osteolabs is a company based in Kiel (Germany) founded in 2019. Osteolabs has raised $1.12 million across 1 funding round from investors including MBG Schleswig-Holstein and Labor Dr. Krause. Osteolabs offers products and services including CIM-Biomarker. Osteolabs operates in a competitive market with competitors including CD Diagnostics, Imagen, Emovi, Kumudha Health Tech and MuscleSound, among others.

  • Headquarter Kiel, Germany
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Evonik Industries Ag
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1.12 M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.12 M (USD), Seed

    Jun 17, 2019

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Osteolabs

Osteolabs offers a comprehensive portfolio of products and services, including CIM-Biomarker.

Product name locked
Category locked
Primary

Measures bone density changes for early detection of metabolic bone diseases.

People of Osteolabs

Headcount 1-10
Employee Profiles 9
Board Members and Advisors 1
Employee Profiles
People
Stefan Kloth
Managing Director
People
Chris Brain
Commercial Manager
People
Kathrin Hagen
Management Assistant
People
Marion Meinen
Office Assistance & Event Organisation

Unlock access to complete

Board Members and Advisors
people
Michael Lutz
Advisor

Unlock access to complete

Funding Insights of Osteolabs

Osteolabs has successfully raised a total of $1.12M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.12 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Osteolabs

Osteolabs has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include MBG Schleswig-Holstein and Labor Dr. Krause.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Medical laboratory services are provided for diagnostic purposes.
Locked Locked Locked
Premium access

Investor details for Osteolabs

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Osteolabs

Investments
Premium access

Investment portfolio details for Osteolabs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Osteolabs

Premium access

Detailed financials for Osteolabs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Osteolabs Comparisons

Osteolabs Primary company
Description
Diagnostic tests for osteoporosis are provided via urine-bas...
Location
Kiel, Germany
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Osteolabs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Osteolabs

Osteolabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CD Diagnostics, Imagen, Emovi, Kumudha Health Tech and MuscleSound, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Synovial fluid is tested for biomarkers in orthopedic disorders.
Locked Locked Locked
AI solutions for detecting pathologies in medical images are developed.
Locked Locked Locked
Developer of a knee assessment device
Locked Locked Locked
Provider of a diagnostic device for spinal deformities
Locked Locked Locked
Muscular glycogen levels are measured non-invasively via ultrasound.
Premium access

Detailed competitors of Osteolabs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Osteolabs

Premium access

Complete news archive for Osteolabs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Osteolabs

Osteolabs was founded in 2019.

Osteolabs is headquartered in Kiel, Germany. It is registered at Kiel, Schleswig-holstein, Germany.

Stefan Kloth is the current CEO of Osteolabs.

Osteolabs is a funded company, having raised a total of $1.12M across 1 funding round to date.

Osteolabs was founded in 2019 in Kiel, Germany, and operates in the healthcare diagnostics sector. An assay is offered by the company that detects trace elements in urine as biomarkers for early osteoporosis diagnosis. Services focus on non-invasive testing to identify the condition in individuals. The domain osteolabs.de is used for operations, with Stefan Kloth serving as CEO.

Osteolabs's top competitors include CD Diagnostics, Imagen and Emovi.

Osteolabs offers CIM-Biomarker.

Osteolabs has 2 investors. Key investors include MBG Schleswig-Holstein, and Labor Dr. Krause.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available